EMILIO
BOUZA SANTIAGO
Investigador hasta 2020
![Foto de EMILIO](/img/nophoto.png)
![Foto de Mutua de Terrassa](/img/noimage_org.png)
Mutua de Terrassa
Terrassa, EspañaPublicaciones en colaboración con investigadores/as de Mutua de Terrassa (17)
2023
-
Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort
International Journal of Infectious Diseases, Vol. 137, pp. 134-143
2020
-
Chronic obstructive pulmonary disease (COPD) in Spain and the different aspects of its social impact: A multidisciplinary opinion document
Revista Espanola de Quimioterapia, Vol. 33, Núm. 1, pp. 49-67
2018
-
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients
Clinical Microbiology and Infection, Vol. 24, Núm. 5, pp. 546.e1-546.e8
2012
-
Pneumonia treated in the internal medicine department: Focus on healthcare-associated pneumonia
Clinical Microbiology and Infection, Vol. 18, Núm. 8, pp. 786-794
2009
-
Management of methicillin-resistant Staphylococcus aureus infections
Clinical Microbiology and Infection, Vol. 15, Núm. 2, pp. 125-136
2008
-
Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277
2007
-
Impact of amoxicillin, associated or not with clavulanic acid, on pharyngeal colonization and selection of Streptococcus pneumoniae resistance in children under 5 years of age
European Journal of Pediatrics, Vol. 166, Núm. 5, pp. 467-471
2006
-
Alterations of the penicillin-binding proteins and murM alleles of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin in Spain
Journal of Antimicrobial Chemotherapy, Vol. 57, Núm. 2, pp. 224-229
-
Combinations of PBPs and MurM protein variants in early and contemporary high-level penicillin-resistant Streptococcus pneumoniae isolates in Spain
Journal of Antimicrobial Chemotherapy, Vol. 57, Núm. 5, pp. 983-986
2005
-
New mutations and horizontal transfer of rpoB among rifampin-resistant Streptococcus pneumoniae from four Spanish hospitals
Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 6, pp. 2237-2245
2004
-
Fluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae Clones, Spain
Emerging Infectious Diseases, Vol. 10, Núm. 10, pp. 1751-1759
-
Spectrum of antibiotic resistance of the Spain14-5 Streptococcus pneumoniae clone over a 22 year period
Journal of Antimicrobial Chemotherapy, Vol. 53, Núm. 4, pp. 620-625
2003
-
Oral pharmacokinetically enhanced co-amoxiclav 2000/125 mg, twice daily, compared with co-amoxiclav 875/125 mg, three times daily, in the treatment of community-acquired pneumonia in European adults
Journal of Antimicrobial Chemotherapy, Vol. 52, Núm. 5, pp. 826-836
-
Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model
Journal of Antimicrobial Chemotherapy, Vol. 52, Núm. 6, pp. 967-973
-
The epidemiology of antibiotic resistance in Streptococcus pneumoniae and the clinical relevance of resistance to cephalosporins, macrolides and quinolones
International Journal of Antimicrobial Agents
2002
-
Meningitis neumocócica en niños Españoles: Incidencia, serotipos y resistencia antibiótica. Estudio prospectivo multicéntrico
Anales Espanoles de Pediatria, Vol. 57, Núm. 4, pp. 295-300
1999
-
Influence of comorbidity and severity on the clinical outcome of bacteremic pneumococcal pneumonia treated with β-lactam monotherapy
Journal of Chemotherapy, Vol. 11, Núm. 4, pp. 266-272